ZME Science on MSN52m
An Experimental Drug Just Slashed Genetic Heart Risk by 94%On Sunday, researchers announced that an experimental drug from Eli Lilly, lepodisiran, reduced levels of Lp (a) by a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback